eriodictyol has been researched along with epidermal growth factor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bode, AM; Cho, EJ; Cho, YY; Dong, Z; Kim, DJ; Lee, MH; Liu, K; Nadas, J; Pugliese, A; Yao, K; Zhang, J | 1 |
1 other study(ies) available for eriodictyol and epidermal growth factor
Article | Year |
---|---|
Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.
Topics: Activating Transcription Factor 1; Animals; Cell Line; Cell Transformation, Neoplastic; Epidermal Growth Factor; Flavanones; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Protein Structure, Tertiary; ras Proteins; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Transcriptional Activation | 2011 |